A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Clinical trial NCT06305234 · RECRUITING
Trial details
- NCT number
- NCT06305234
- Sponsor
- BioMarin Pharmaceutical
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-20
- Primary completion
- 2033-11-18
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.